$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000143774919016848 Filed on August 14, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q2
Revenue	$452.7K	$728.4K	$748.1K
YoY Change	-38.8%	-2.64%	-15.64%
Cost Of Revenue	$508.7K	$679.4K	$1.030M
YoY Change	-45.91%	-34.02%	29.38%
Gross Profit	-$55.94K	$48.96K	-$281.7K
YoY Change	-72.11%	-117.38%	-409.79%
Gross Profit Margin	-12.36%	6.72%	-37.65%
Selling, General & Admin	$915.1K	$1.059M	$1.076M
YoY Change	-12.79%	-1.63%	-24.81%
% of Gross Profit		2162.45%
Research & Development	$300.1K	$301.2K	$297.6K
YoY Change	-23.34%	1.2%	-33.72%
% of Gross Profit		615.27%
Depreciation & Amortization	$300.0K	$310.0K	$680.0K
YoY Change	-56.52%	-54.41%	65.85%
% of Gross Profit		633.21%
Operating Expenses	$1.215M	$1.360M	$1.374M
YoY Change	-15.66%	-1.01%	-26.93%
Operating Profit	-$558.4K	-$114.8K	-$1.655M
YoY Change	-65.98%	-93.06%	-7.48%
Interest Expense	$558.4K	$114.9K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$1.271M	-$1.311M
YoY Change
Pretax Income	-$1.830M	-$1.430M	-$1.660M
YoY Change	11.59%	-13.86%	-7.26%
Income Tax
% Of Pretax Income
Net Earnings	-$1.830M	-$1.426M	-$1.655M
YoY Change	11.47%	-13.88%	-7.48%
Net Earnings / Revenue	-404.13%	-195.74%	-221.28%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.017M	-$812.5K	-$1.169M
COMMON SHARES
Basic Shares Outstanding	14.40M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$590.0K	$690.0K	$300.0K
YoY Change	-43.81%	130.0%	-69.7%
Cash & Equivalents	$78.24K	$687.0K	$304.0K
Short-Term Investments	$510.0K
Other Short-Term Assets	$50.70K	$138.6K	$27.66K
YoY Change	-36.94%	400.91%	-6.11%
Inventory	$971.2K	$1.012M	$930.5K
Prepaid Expenses
Receivables	$773.3K	$689.9K	$491.7K
Other Receivables	$50.00K	$140.0K	$30.00K
Total Short-Term Assets	$3.694M	$3.814M	$4.730M
YoY Change	-37.48%	-19.37%	-0.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$117.6K	$137.5K	$189.4K
YoY Change	-30.81%	-27.41%	23.34%
Goodwill
YoY Change
Intangibles	$187.7K	$191.0K	$187.8K
YoY Change	-2.75%	1.7%	12.65%
Long-Term Investments
YoY Change
Other Assets	$260.0K	$290.0K	$350.0K
YoY Change	-23.53%	-17.14%	3400.0%
Total Long-Term Assets	$7.087M	$7.342M	$7.873M
YoY Change	-0.07%	-6.75%	-26.09%
TOTAL ASSETS
Total Short-Term Assets	$3.694M	$3.814M	$4.730M
Total Long-Term Assets	$7.087M	$7.342M	$7.873M
Total Assets	$10.78M	$11.16M	$12.60M
YoY Change	-17.07%	-11.49%	-18.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$496.7K	$864.9K	$330.4K
YoY Change	34.31%	161.74%	-0.96%
Accrued Expenses	$478.5K	$714.3K	$484.6K
YoY Change	-18.28%	47.4%	15.01%
Deferred Revenue	$222.7K	$294.3K	$328.2K
YoY Change	-12.91%	-10.34%
Short-Term Debt	$1.860M	$540.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.236M	$2.699M	$1.143M
YoY Change	167.16%	136.07%	-42.12%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$430.0K	$380.0K
YoY Change
Total Long-Term Liabilities	$426.9K	$383.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.236M	$2.699M	$1.143M
Total Long-Term Liabilities	$426.9K	$383.0K	$0.00
Total Liabilities	$3.663M	$3.082M	$1.143M
YoY Change	202.41%	169.58%	-42.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$80.19M	-$78.36M	-$70.68M
YoY Change	8.73%	10.86%	7.18%
Common Stock	$1.440K	$1.429K	$1.259K
YoY Change	3.0%	13.5%	93.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.119M	$8.074M	$11.46M
YoY Change
Total Liabilities & Shareholders Equity	$10.78M	$11.16M	$12.60M
YoY Change	-17.07%	-11.49%	-18.09%

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$1.830M	-$1.426M	-$1.655M
YoY Change	11.47%	-13.88%	-7.48%
Depreciation, Depletion And Amortization	$300.0K	$310.0K	$680.0K
YoY Change	-56.52%	-54.41%	65.85%
Cash From Operating Activities	-$1.620M	-$420.0K	-$940.0K
YoY Change	58.82%	-55.32%	-3.09%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$10.00K	-$40.00K
YoY Change	-100.0%	-75.0%	-69.23%
Acquisitions
YoY Change
Other Investing Activities	-$510.0K	$0.00
YoY Change
Cash From Investing Activities	-$510.0K	$0.00	-$40.00K
YoY Change	5000.0%	-100.0%	-69.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.530M	650.0K	-20.00K
YoY Change	-14.04%	-3350.0%	-102.15%
NET CHANGE
Cash From Operating Activities	-1.620M	-420.0K	-940.0K
Cash From Investing Activities	-510.0K	0.000	-40.00K
Cash From Financing Activities	1.530M	650.0K	-20.00K
Net Change In Cash	-600.0K	230.0K	-1.000M
YoY Change	-180.0%	-123.0%	488.24%
FREE CASH FLOW
Cash From Operating Activities	-$1.620M	-$420.0K	-$940.0K
Capital Expenditures	$0.00	-$10.00K	-$40.00K
Free Cash Flow	-$1.620M	-$410.0K	-$900.0K
YoY Change	60.4%	-54.44%	7.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	bkyi	Accrual Of Unpaid Preferred Stock Dividends AccrualOfUnpaidPreferredStockDividends
	bkyi	Accrual Of Unpaid Preferred Stock Dividends AccrualOfUnpaidPreferredStockDividends	198033
CY2019Q2	bkyi	Adjustments To Additional Paid In Capital Commitment Fee Adjustment AdjustmentsToAdditionalPaidInCapitalCommitmentFeeAdjustment	270000
CY2018Q1	bkyi	Adjustments To Additional Paid In Capital Preferred Stock Dividends Declared AdjustmentsToAdditionalPaidInCapitalPreferredStockDividendsDeclared	156162
CY2018Q2	bkyi	Adjustments To Additional Paid In Capital Preferred Stock Dividends Declared AdjustmentsToAdditionalPaidInCapitalPreferredStockDividendsDeclared	41871
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	562150
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	1318559
CY2019Q2	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	281076
	bkyi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets	70180
	bkyi	Change In Operating Lease Rightofuse Assets ChangeInOperatingLeaseRightofuseAssets
CY2018Q2	bkyi	Conversion Of A1 Preferred Dividends Payable Amount Converted ConversionOfA1PreferredDividendsPayableAmountConverted	356015
CY2018Q1	bkyi	Conversion Of B1 Preferred Dividends Payable Amount Converted ConversionOfB1PreferredDividendsPayableAmountConverted	417083
CY2018Q2	bkyi	Conversion Of B1 Preferred Dividends Payable Amount Converted ConversionOfB1PreferredDividendsPayableAmountConverted	55341
CY2018Q1	bkyi	Cumulative Effect Of New Accounting Standard In Period Of Adoption CumulativeEffectOfNewAccountingStandardInPeriodOfAdoption	240017
CY2019Q2	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-416507
CY2018Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-164438
CY2019Q2	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	555075
CY2018Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	221120
	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
	dei	Document Type DocumentType	10-Q
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Security12b Title Security12bTitle	Common Stock
CY2018Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	6790610
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	22011
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	23021
CY2019Q2	bkyi	Stock Issued During Period Shares Commitment Fees StockIssuedDuringPeriodSharesCommitmentFees	80000
CY2019Q2	bkyi	Stock Issued During Period Shares Commitment Fees StockIssuedDuringPeriodSharesCommitmentFees	200000
CY2019Q2	bkyi	Factoring Fees FactoringFees	39543
CY2018Q2	bkyi	Factoring Fees FactoringFees	12691
	bkyi	Factoring Fees FactoringFees	92340
	bkyi	Factoring Fees FactoringFees	104214
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	26861
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	160649
	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-66246
	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-35043
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-9543
	bkyi	Monthly Cash Requirement To Conduct Operations And Pay Dividend Obligations MonthlyCashRequirementToConductOperationsAndPayDividendObligations	537000
	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2018	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	635077
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	676454
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	180000
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees
CY2019Q2	bkyi	Software License Rights SoftwareLicenseRights	7318417
CY2018Q4	bkyi	Software License Rights SoftwareLicenseRights	7915610
CY2019Q2	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent	1125000
CY2018Q4	bkyi	Software License Rights Current SoftwareLicenseRightsCurrent	1125000
CY2019Q2	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	6193417
CY2019Q2	bkyi	Stock Issued During Period Shares Commitment Fees StockIssuedDuringPeriodSharesCommitmentFees	300000
CY2019Q2	bkyi	Stock Issued During Period Value Commitment Fees StockIssuedDuringPeriodValueCommitmentFees	450000
CY2018Q1	bkyi	Stock Issued During Period Value Conversion Of B1 Preferred Stock StockIssuedDuringPeriodValueConversionOfB1PreferredStock
CY2018Q2	bkyi	Stock Issued During Period Value Conversion Of B1 Preferred Stock StockIssuedDuringPeriodValueConversionOfB1PreferredStock
CY2019Q2	bkyi	Stock Returned To Company Prepayment Of Debt Covenant StockReturnedToCompanyPrepaymentOfDebtCovenant	180000
CY2019Q2	bkyi	Stock To Be Issued Monthly Shares Payment Of Commitment Fees StockToBeIssuedMonthlySharesPaymentOfCommitmentFees	10000
CY2018Q2	bkyi	Stockholders Equity Rounding Adjustment StockholdersEquityRoundingAdjustment	1
CY2019Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	138568
CY2018Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	56682
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	864879
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	481269
CY2019Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	142623
CY2018Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	0
CY2019Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2423685
CY2018Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3307817
CY2019Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	703685
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1587817
CY2019Q2	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2018Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2019Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	689900
CY2018Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1574032
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	689900
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1574032
CY2019Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	714250
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	548232
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	86436197
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85599140
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001019034
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14397015
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BIO KEY INTERNATIONAL INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	bkyi
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	509528
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	125549
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	533421
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	143034
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	15212
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	131054
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	149542
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	657088
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	699475
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	15467
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	56200
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6628
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8966
CY2019Q2	us-gaap	Assets Assets	11155835
CY2018Q4	us-gaap	Assets Assets	11692332
CY2019Q1	us-gaap	Assets Assets	12282674
CY2019Q2	us-gaap	Assets Current AssetsCurrent	3814191
CY2018Q4	us-gaap	Assets Current AssetsCurrent	4229297
CY2019Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	7341644
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	7463035
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	67774
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	59044
CY2019Q2	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	687023
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323943
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288721
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	304006
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	363080
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	15285
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14295923
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13977868
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14295923
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1283476
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2209248
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	40000
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2019Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13977868
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	1429
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1398
CY2019Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	278286
CY2018Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	319199
CY2019Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	294261
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	196609
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	294261
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	196609
CY2019Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	34000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	111000
CY2018	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2018Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	679426
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1029803
CY2018Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
	us-gaap	Depreciation Depreciation	39903
	us-gaap	Depreciation Depreciation	44596
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2019Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-114812
CY2018Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	14
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-114742
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	21
CY2019Q2	us-gaap	Gross Profit GrossProfit	48957
CY2018Q2	us-gaap	Gross Profit GrossProfit	-281662
	us-gaap	Gross Profit GrossProfit	-3470
	us-gaap	Gross Profit GrossProfit	-619652
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	526233
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-168799
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-884132
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2424295
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	166018
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-203445
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	97652
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-179683
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12874
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-16369
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	81886
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-82202
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23781
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4041
CY2019Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	191014
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	195906
CY2019Q2	us-gaap	Interest Expense InterestExpense	114866
CY2018Q2	us-gaap	Interest Expense InterestExpense
	us-gaap	Interest Expense InterestExpense	114866
	us-gaap	Interest Expense InterestExpense
CY2019Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	54
CY2018Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	124
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21
	us-gaap	Interest Paid Net InterestPaidNet
	us-gaap	Interest Paid Net InterestPaidNet
CY2019Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	499426
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-1655465
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-68479
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1425743
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	496358
CY2019Q2	us-gaap	Inventory Net InventoryNet	1011703
CY2018Q4	us-gaap	Inventory Net InventoryNet	998829
CY2019Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	512277
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	502471
CY2019Q2	us-gaap	Lease Cost LeaseCost	58075
	us-gaap	Lease Cost LeaseCost	117352
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	586799
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	89226
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	131249
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	127425
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	155682
CY2019Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	83217
CY2019Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	62703
CY2019Q2	us-gaap	Liabilities Liabilities	3081776
CY2018Q4	us-gaap	Liabilities Liabilities	1226110
CY2019Q1	us-gaap	Liabilities Liabilities	1816452
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11155835
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11692332
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12282674
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2698748
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1226110
CY2019Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	383028
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	650000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15212
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30489
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-256431
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	98976
	us-gaap	Net Income Loss NetIncomeLoss	-3229251
	us-gaap	Net Income Loss NetIncomeLoss	-3847456
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-1803508
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-2191992
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1425743
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1697335
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3229251
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4045489
CY2019Q2	us-gaap	Notes Payable Current NotesPayableCurrent	541667
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	1359888
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	1373817
	us-gaap	Operating Expenses OperatingExpenses	3111039
	us-gaap	Operating Expenses OperatingExpenses	3227825
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1310931
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1655479
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3114509
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3847477
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	42981
	us-gaap	Operating Lease Cost OperatingLeaseCost	85962
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	524096
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	141068
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	135519
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	383028
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	454823
	us-gaap	Operating Lease Payments OperatingLeasePayments	84231
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	532757
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	602937
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y328D
CY2019Q2	us-gaap	Other Assets Current OtherAssetsCurrent	138568
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56682
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	17000
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	15212
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1736
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28753
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68479
CY2019Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2018Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	41870
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	198033
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	161997
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	150811
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	138216
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;">Reclassification</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications including segregating the hardware revenues. The reclassifications have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the reported net loss.</div></div></div>
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	667000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137458
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	148608
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	728383
CY2018Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	748141
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1280006
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1589596
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	301217
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	297633
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	675335
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	689787
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78363567
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-75134316
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1058671
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1076184
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2435704
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2538038
CY2019Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	15094
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	31390
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16506
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5505
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16513
CY2018Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6509
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	8074059
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10466222
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	9188748
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	13753295
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	12612175
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	11460527
CY2019Q2	us-gaap	Sublease Income SubleaseIncome
	us-gaap	Sublease Income SubleaseIncome
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14117062
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11375320
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14048570
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9623151

Files In Submission

Name	View Source	Status
0001437749-19-016848-index-headers.html	Edgar Link	pending
0001437749-19-016848-index.html	Edgar Link	pending
0001437749-19-016848.txt	Edgar Link	pending
0001437749-19-016848-xbrl.zip	Edgar Link	pending
bkyi-20190630.xml	Edgar Link	completed
bkyi-20190630.xsd	Edgar Link	pending
bkyi-20190630_cal.xml	Edgar Link	unprocessable
bkyi-20190630_def.xml	Edgar Link	unprocessable
bkyi-20190630_lab.xml	Edgar Link	unprocessable
bkyi-20190630_pre.xml	Edgar Link	unprocessable
bkyi20190630_10q.htm	Edgar Link	pending
ex_154276.htm	Edgar Link	pending
ex_154277.htm	Edgar Link	pending
ex_154281.htm	Edgar Link	pending
ex_154282.htm	Edgar Link	pending
ex_154283.htm	Edgar Link	pending
ex_154642.htm	Edgar Link	pending
ex_154643.htm	Edgar Link	pending
ex_154644.htm	Edgar Link	pending
ex_154645.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q3 Form 10-Q Financial Statement

#000143774919016848 Filed on August 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2019 Q3 Form 10-Q Financial Statement

#000143774919016848 Filed on August 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi